Clinical significance of lipid profile in systemic lupus erythematosus patients: Relation to disease activity and therapeutic potential of drugs

Manzi, 1997, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study, Am J Epidemiol, 145, 408, 10.1093/oxfordjournals.aje.a009122 Petri, 1992, Risk factors for coronary artery disease in patients with systemic lupus erythematosus, Am J Med, 93, 513, 10.1016/0002-9343(92)90578-Y Borba, 2000, Chylomicron metabolism is markedly altered in systemic lupus erythematosus, Arthritis Rheum, 43, 1033, 10.1002/1529-0131(200005)43:5<1033::AID-ANR11>3.0.CO;2-B Borba, 2001, Long term beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy, J Rheumatol, 28, 780 Nuttall, 2003, Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia, Rheumatology (Oxford), 42, 758, 10.1093/rheumatology/keg212 Svenungsson, 2003, Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosus, Arthritis Rheum, 48, 2533, 10.1002/art.11264 Petri, 1994, Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal analysis, Am J Med, 96, 254, 10.1016/0002-9343(94)90151-1 Sella, 2003, Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus, Ann Rheum Dis, 62, 1066, 10.1136/ard.62.11.1066 Borba, 1997, Dyslipoproteinemias in systemic lupus erythematosus: influence of disease activity and anticardiolipin antibodies, Lupus, 6, 533, 10.1177/096120339700600610 Beynen, 1981, Inhibition of hepatic cholesterol biosynthesis by chloroquine, Lipids, 16, 472, 10.1007/BF02535017 Matasuzama, 1980, Studies in drug-induced lipidosis: subcellular localization of phospholipid and cholesterol in the liver of rats treated with chloroquine o-4, 4-bis (diethylaminoethoxy) α β-diethyldihenylethane, J Lipid Res, 21, 202, 10.1016/S0022-2275(20)39826-6 Oram, 1981, The effects of subtractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts, J Biol Chem, 256, 8348, 10.1016/S0021-9258(19)68850-2 Quatraro, 1990, Hydroxychloroquine in decompensated treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?, Ann Intern Med, 112, 678, 10.7326/0003-4819-112-9-678 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Hodis, 1993, The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus, J Rheumatol, 20, 661 Tam, 2000, Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus, J Rheumatol, 27, 2142 Mikdashi, 2007, Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus, Stroke, 38, 281, 10.1161/01.STR.0000254476.05620.14 Liang, 1989, Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus, Arthritis Rheum, 32, 1107, 10.1002/anr.1780320909 Bruce, 2000, Premature atherosclerosis in systemic lupus erythematosus, Rheum Dis Clin North Am, 26, 257, 10.1016/S0889-857X(05)70138-1 Ward, 1999, Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus, Arthritis Rheum, 42, 338, 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U Ardoin, 2007, Management of dyslipidemia in children and adolescents with systemic lupus erythematosus, Lupus, 16, 618, 10.1177/0961203307079566 Bruce, 2003, Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study, Arthritis Rheum, 48, 3159, 10.1002/art.11296 Gamal, 2016, Immunological profile and dyslipidemia in Egyptian Systemic Lupus Erythematosus patients, Egypt Rheumatol, 10.1016/j.ejr.2016.05.007 Rossoni, 2011, Antimalarials and cholesterol profile of patients with systemic lupus erythematosus, Rev Bras Rheumatol, 51, 383 Tam, 2000, Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease, Lupus, 9, 413, 10.1191/096120300678828541 Wallace, 1990, Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids, Am J Med, 89, 322, 10.1016/0002-9343(90)90345-E Rahman, 1999, The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs, J Rheumatol, 26, 325 Sarkissian, 2006, The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus, Arthritis Rheum, 54, 1283, 10.1002/art.21748 Rho, 2008, Drugs to treat systemic lupus erythematosus: relationship between current use and cardiovascular risk factors, Arch Drug Info, 1, 23, 10.1111/j.1753-5174.2007.00004.x Muntner, 2000, Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study, Kidney Int, 58, 293, 10.1046/j.1523-1755.2000.00165.x Crook, 2003, Lipid abnormalities and renal disease: is dyslipidemia a predictor of progression of renal disease?, Am J Med Sci, 325, 340, 10.1097/00000441-200306000-00005 Schaeffner, 2003, Cholesterol and the risk of renal dysfunction in apparently healthy men, J Am Soc Nephrol, 14, 2084, 10.1681/ASN.V1482084 Tisseverasinghe, 2006, Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus, Arthritis Rheum, 54, 2211, 10.1002/art.21929 Korhonen, 1996, Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women, Atherosclerosis, 127, 213, 10.1016/S0021-9150(96)05958-8 Gotto, 1998, Triglyceride as a risk factor for coronary artery disease, Am J Cardiol, 82, 22Q, 10.1016/S0002-9149(98)00770-X